PMID: 7039371Apr 1, 1982Paper

The experimental evidence for weight-loss treatment of essential hypertension: a critical review

American Journal of Public Health
M F Hovell

Abstract

The empirical evidence concerning the therapeutic effects of weight loss for hypertension treatment was reviewed. Interventions were critically reviewed for strength of measures and experimental design. Six of 21 intervention studies proved to be methodologically strong. However, only one study was considered a randomized clinical trial, testing the combined effects of weight reduction and pharmacological treatment of hypertension. Average blood pressure decrease obtained from the methodologically strongest studies was -21 mmHg and -13 mmHg, for systolic and diastolic measures, respectively. This magnitude change suggests that weight loss may be a clinically and statistically significant treatment. Confounding and bias variables, such as adherence to diet, medication, salt consumption, etc., were discussed and future areas of research were outlined. It was concluded that weight loss appears to be an effective and safe treatment of hypertension.

References

Jan 1, 1977·Scottish Medical Journal·K O'Malley
Mar 1, 1977·Archives of General Psychiatry·C B TaylorS Agras
May 1, 1979·The American Journal of Medicine·H R Black
Jan 1, 1979·Journal of Chronic Diseases·J SouchekM H Lepper
Jan 1, 1979·Journal of Applied Behavior Analysis·S C WooleyS R Dyrenforth
Nov 1, 1979·American Heart Journal·K D LaughlinD J Sherrard
Jan 1, 1977·Journal of Applied Behavior Analysis·R S SurwitT Feldman
Jun 10, 1978·British Medical Journal·R G Wilcox
Jul 22, 1978·British Medical Journal·L E RamsayJ Winchester
Oct 6, 1978·JAMA : the Journal of the American Medical Association·R StamlerR H Roberts
Dec 1, 1978·Journal of Epidemiology and Community Health·R F HellerD G Christie
Jan 6, 1979·British Medical Journal·R T JungW P James
Feb 1, 1977·Journal of Chronic Diseases·P H HsuS W Rabkin
May 1, 1977·The American Journal of Clinical Nutrition·J L KnittleR E Brown
Jan 1, 1977·Behaviour Research and Therapy·E E Abramson
Aug 14, 1972·JAMA : the Journal of the American Medical Association·T Gordon, W B Kannel
Nov 18, 1974·JAMA : the Journal of the American Medical Association·S M GenuthV Vertes
Aug 1, 1973·Clinical Science and Molecular Medicine. Supplement·B C JohnsonF H Epstein
Mar 1, 1974·Journal of Chronic Diseases·F W Ashley, W B Kannel
Mar 1, 1969·Circulation·B N ChiangF H Epstein
Sep 7, 1970·JAMA : the Journal of the American Medical Association·E Boyle
Dec 1, 1970·American Journal of Epidemiology·C C SeltzerJ Mayer
Nov 1, 1970·British Journal of Preventive & Social Medicine·P H SiveE Riss
Apr 1, 1968·British Journal of Preventive & Social Medicine·W E MiallH G Lovell
Feb 1, 1980·Australian and New Zealand Journal of Medicine·P J BrennanC A McGilchrist
Dec 26, 1953·Journal of the American Medical Association·A M MASTERK CHESKY
Oct 30, 1957·Acta Medica Scandinavica·T BJERKEDAL
Jun 12, 1958·The New England Journal of Medicine·L K DAHLR W CHRISTIE
Mar 1, 1959·Circulation·S PADMAVATI, S GUPTA
Apr 1, 1959·Circulation·H M WHYTE

❮ Previous
Next ❯

Citations

Jul 1, 1990·Archives of Gerontology and Geriatrics·G PaolissoF D'Onofrio
Jan 1, 1990·Social Science & Medicine·M Fleming-Moran, C E Coimbra Júnior
Jan 1, 1985·Addictive Behaviors·M F HovellS Fowler-Johnson
Jan 1, 1989·Psychosomatics·T R Garrick, R J Loewenstein
Oct 29, 1988·Lancet·V HoffsteinA S Slutsky
Mar 24, 2000·Journal of Clinical Epidemiology·G H GuyattL Griffith
Apr 14, 2000·Journal of Cardiopulmonary Rehabilitation·M BrochuP A Ades
Mar 11, 2010·American Journal of Therapeutics·Christian FouilliouxValmore Bermúdez
Mar 1, 1985·The Journal of School Health·R P FarrisG S Berenson
Aug 29, 1987·British Medical Journal·I N FindlayB M Fisher
Jul 30, 1988·BMJ : British Medical Journal·J D Swales
Mar 1, 1985·The Journal of Clinical Investigation·M ModanZ Fuchs
Oct 5, 1984·The American Journal of Medicine·N M Kaplan
Feb 1, 1992·Controlled Clinical Trials·K Ottenbacher
Jun 1, 1988·American Journal of Public Health·M F HovellV J Felitti
Mar 14, 2009·Journal of Clinical Epidemiology·Anne M MoseleyCatherine Sherrington
Jun 1, 1984·Current Problems in Pediatrics·L O Watkins, W B Strong
Apr 1, 1989·Statistics in Medicine·G A ColditzF Mosteller
Jul 16, 2005·The American Journal of Cardiology·Serena TonstadMartin Fitchet
Feb 1, 2003·Journal of Evaluation in Clinical Practice·J Ian S Robertson
Mar 1, 2002·The Australian Journal of Physiotherapy·Anne M MoseleyChristopher G Maher
Aug 1, 1991·Journal of the American College of Nutrition·R L HancockJ J Anderson
May 24, 2006·International Journal of Obesity : Journal of the International Association for the Study of Obesity·V A DiazC Pope
Apr 15, 2011·The Cochrane Database of Systematic Reviews·Jan Odgaard-JensenAndrew D Oxman
Jun 8, 2013·Physical Therapy·Silvia GianolaLorenzo Moja
Sep 8, 2019·Journal of Clinical Medicine·Roman Jurik, Petr Stastny
Mar 14, 2020·Diabetes, Obesity & Metabolism·Ayla CoussaJosé A Morais
Jan 1, 1982·Western Journal of Nursing Research·K E Barnard
Jan 1, 1987·Scandinavian Journal of Social Medicine·B J Haglund

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.